loadpatents
Patent applications and USPTO patent grants for Miner; Jeffrey.The latest application filed is for "treatment of gout and hyperuricemia".
Patent | Date |
---|---|
CXCR-2 inhibitors for treating crystal arthropathy disorders Grant 10,772,886 - Nanavati , et al. Sept | 2020-09-15 |
Treatment of Gout and Hyperuricemia App 20190015392 - Miner; Jeffrey ;   et al. | 2019-01-17 |
Cxcr-2 Inhibitors For Treating Crystal Arthropathy Disorders App 20180235964 - NANAVATI; Payal ;   et al. | 2018-08-23 |
Treatment Of Gout App 20160374993 - MINER; Jeffrey ;   et al. | 2016-12-29 |
Treatment of gout Grant 9,402,827 - Miner , et al. August 2, 2 | 2016-08-02 |
Treatment Of Gout And Hyperuricemia App 20160143889 - MINER; Jeffrey ;   et al. | 2016-05-26 |
Treatment of gout and hyperuricemia Grant 9,216,179 - Miner , et al. December 22, 2 | 2015-12-22 |
Hypertension And Hyperuricemia App 20140171424 - Miner; Jeffrey | 2014-06-19 |
Treatment Of Gout And Hyperuricemia App 20130178484 - Miner; Jeffrey ;   et al. | 2013-07-11 |
Treatment Of Gout App 20130059868 - Miner; Jeffrey ;   et al. | 2013-03-07 |
Combinations Of Mek Inhibitors And Raf Kinase Inhibitors And Uses Thereof App 20120136030 - MINER; Jeffrey ;   et al. | 2012-05-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.